Cargando…
Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222404/ https://www.ncbi.nlm.nih.gov/pubmed/35786362 http://dx.doi.org/10.1016/j.hbpd.2022.06.010 |
| _version_ | 1784732865723891712 |
|---|---|
| author | Tian, Qiu-Ju Xie, Man Wang, Ji-Tao Wang, Yi Zhang, Bei Cai, Jin-Zhen Qi, Xiao-Long Rao, Wei |
| author_facet | Tian, Qiu-Ju Xie, Man Wang, Ji-Tao Wang, Yi Zhang, Bei Cai, Jin-Zhen Qi, Xiao-Long Rao, Wei |
| author_sort | Tian, Qiu-Ju |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9222404 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92224042022-06-24 Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China Tian, Qiu-Ju Xie, Man Wang, Ji-Tao Wang, Yi Zhang, Bei Cai, Jin-Zhen Qi, Xiao-Long Rao, Wei Hepatobiliary Pancreat Dis Int Letter to the Editor First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. 2022-12 2022-06-23 /pmc/articles/PMC9222404/ /pubmed/35786362 http://dx.doi.org/10.1016/j.hbpd.2022.06.010 Text en © 2022 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Tian, Qiu-Ju Xie, Man Wang, Ji-Tao Wang, Yi Zhang, Bei Cai, Jin-Zhen Qi, Xiao-Long Rao, Wei Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China |
| title | Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China |
| title_full | Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China |
| title_fullStr | Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China |
| title_full_unstemmed | Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China |
| title_short | Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China |
| title_sort | safety and immunogenicity of covid-19 vaccination among liver transplant recipients in china |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222404/ https://www.ncbi.nlm.nih.gov/pubmed/35786362 http://dx.doi.org/10.1016/j.hbpd.2022.06.010 |
| work_keys_str_mv | AT tianqiuju safetyandimmunogenicityofcovid19vaccinationamonglivertransplantrecipientsinchina AT xieman safetyandimmunogenicityofcovid19vaccinationamonglivertransplantrecipientsinchina AT wangjitao safetyandimmunogenicityofcovid19vaccinationamonglivertransplantrecipientsinchina AT wangyi safetyandimmunogenicityofcovid19vaccinationamonglivertransplantrecipientsinchina AT zhangbei safetyandimmunogenicityofcovid19vaccinationamonglivertransplantrecipientsinchina AT caijinzhen safetyandimmunogenicityofcovid19vaccinationamonglivertransplantrecipientsinchina AT qixiaolong safetyandimmunogenicityofcovid19vaccinationamonglivertransplantrecipientsinchina AT raowei safetyandimmunogenicityofcovid19vaccinationamonglivertransplantrecipientsinchina |